Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03885531 · ClinicalTrials.gov registry record
Safety and Performance of JOURNEY™ II Cruciate Retaining (CR) Total Knee System (TKS)
A clinical trial, sponsored by Smith & Nephew.
- Completed
- Registry status
- 586
- Enrollment target
NCT03885531: Completed study, sponsored by Smith & Nephew.
NCT03885531 is a clinical trial that has completed, run by Smith & Nephew. The registered enrollment target is 586 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03885531 has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- 586 participants
- Enrollment target
Study Summary
The objective of this study is to examine the safety and performance of the Journey II CR TKS based on retrospective data.
Interventions
- DEVICE Total knee arthroplasty with Journey II CR Total Knee System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 586 participants |
| Start Date | 2019-03-27 |
| Est. Completion | 2020-06-30 |
What the finished NCT03885531 record still lists
NCT03885531 is an observational study that tracks outcomes without assigning an intervention. The registered 586 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Total knee arthroplasty with Journey II CR Total Knee System is the first listed.
NCT03885531 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03885531 about?
NCT03885531 is a clinical study titled "Safety and Performance of JOURNEY™ II Cruciate Retaining (CR) Total Knee System (TKS)". The objective of this study is to examine the safety and performance of the Journey II CR TKS based on retrospective data.
What is the current status of trial NCT03885531?
This trial is currently completed. The enrollment target is 586 participants. The study started on 2019-03-27. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT03885531?
The interventions under investigation include: Total knee arthroplasty with Journey II CR Total Knee System (DEVICE).
Who is sponsoring clinical trial NCT03885531?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04134260 · 586 participants · Phase 3
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial
- NCT06100770 · 586 participants
Aveir AR Coverage With Evidence Development (CED) Study
- NCT06183281 · 586 participants · NA
Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity
- NCT06976203 · 586 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI